These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10578289)

  • 41. Effect of peritransplant FTY720 alone or in combination with post-transplant tacrolimus in a rat model of cardiac allotransplantation.
    Xu M; Pirenne J; Antoniou EA; Afford SC; D'Silva M; McMaster P
    Transpl Int; 1998; 11(4):288-94. PubMed ID: 9704394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.
    Mayer K; Birnbaum F; Reinhard T; Reis A; Braunstein S; Claas F; Sundmacher R
    Br J Ophthalmol; 2004 Jul; 88(7):915-9. PubMed ID: 15205237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FTY720 inhibits the mRNA expression of intragraft cytotoxic molecules, leading to cardiac allograft survival.
    Nakajima H; Sun E; Mizuta N; Fujiwara I; Oka T
    Transplant Proc; 1998 Aug; 30(5):2217-20. PubMed ID: 9723446
    [No Abstract]   [Full Text] [Related]  

  • 44. FTY720, a novel immunosuppressant, prolongs rat skin allograft survival by decreasing T-cell infiltration into grafts.
    Yanagawa Y; Hoshino Y; Kataoka H; Kawaguchi T; Ohtsuki M; Sugahara K; Chiba K
    Transplant Proc; 1999; 31(1-2):1227-9. PubMed ID: 10083548
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice.
    Kataoka H; Ohtsuki M; Shimano K; Mochizuki S; Oshita K; Murata M; Sugahara K; Sato N; Hoshino Y; Chiba K
    Transplant Proc; 2005; 37(1):107-9. PubMed ID: 15808562
    [No Abstract]   [Full Text] [Related]  

  • 46. Donor pretreatment with FTY720 increases graft lymphocytes but does not affect graft survival following rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transplant Proc; 2002 May; 34(3):973-4. PubMed ID: 12034266
    [No Abstract]   [Full Text] [Related]  

  • 47. Neointima suppression in rat carotid allografts by FTY720 combined with a small fixed cyclosporine dose is related to a diminution of the peripheral lymphocyte count.
    Nikolova Z; Hof RP
    Transplant Proc; 2001 May; 33(3):2184-5. PubMed ID: 11377496
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
    Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
    Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single-drug, induction and combination treatments.
    Suzuki T; Jin MB; Shimamura T; Yamashita K; Taniguchi M; Nomura M; Yokota R; Fukai M; Magata S; Horiuchi H; Fujita M; Nagashima K; Furukawa H; Todo S
    Transpl Int; 2004 Nov; 17(10):574-84. PubMed ID: 15592714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression.
    Brinkmann V; Chen S; Feng L; Pinschewer D; Nikolova Z; Hof R
    Transplant Proc; 2001; 33(1-2):530-1. PubMed ID: 11266942
    [No Abstract]   [Full Text] [Related]  

  • 51. FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model.
    Fu F; Hu S; Li S; DeLeo J; Hoover J; Wang S; Lake P; Shi V
    Transplant Proc; 2001; 33(1-2):672-3. PubMed ID: 11267010
    [No Abstract]   [Full Text] [Related]  

  • 52. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation.
    Hwang MW; Matsumori A; Furukawa Y; Ono K; Okada M; Iwasaki A; Hara M; Sasayama S
    Circulation; 1999 Sep; 100(12):1322-9. PubMed ID: 10491378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FTY720 blocks allograft rejection by homing of lymphocytes in vivo.
    Yuzawa K; Stephkowski SM; Wang M; Kahan BD
    Transplant Proc; 2000 Mar; 32(2):269. PubMed ID: 10715413
    [No Abstract]   [Full Text] [Related]  

  • 54. FTY720 alters the composition of T-lymphocyte subpopulations in the peripheral blood compartment of renal transplant patients.
    Boehler T; Schuetz M; Budde K; Neumayer H; Waiser J
    Transplant Proc; 2002 Sep; 34(6):2242-3. PubMed ID: 12270383
    [No Abstract]   [Full Text] [Related]  

  • 55. What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation?
    Xun CQ; Little MT; Zellmer E; Yu C; Zaucha JM; Sale GE; Storer B; Storb R
    Transplantation; 2002 Jan; 73(2):310-3. PubMed ID: 11821753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of a new immunosuppressive agent, FTY720, on survival of islet allografts.
    Yamasaki T; Inoue K; Hayashi H; Gu Y; Setoyama H; Ida J; Cui W; Kawakami Y; Kogire M; Imamura M
    Cell Transplant; 1998; 7(4):403-6. PubMed ID: 9710310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
    Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
    Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats.
    Suzuki S; Enosawa S; Kakefuda T; Li XK; Mitsusada M; Takahara S; Amemiya H
    Transpl Immunol; 1996 Sep; 4(3):252-5. PubMed ID: 8893458
    [No Abstract]   [Full Text] [Related]  

  • 59. Protection of mouse small bowel allografts by FTY720 and costimulation blockade.
    Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW
    Transplantation; 2005 Jun; 79(12):1703-10. PubMed ID: 15973172
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transplantation; 2001 Jul; 72(1):168-71. PubMed ID: 11468555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.